Strong CAGR to Propel in the Psoriatic Arthritis Treatment Market and Beyond upto $17.16 Billion by 2029
Discover trends, market shifts, and competitive outlooks for the psoriatic arthritis treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Are the Key Projections for the CAGR of the Psoriatic Arthritis Treatment Market Size From 2025 to 2034?#_x000D_
The market for treating psoriatic arthritis has notably expanded in the recent past. It is projected to escalate from $10.93 billion in 2024 to $12 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The historic expansion is credited to factors such as heightened diagnosis, surge in psoriatic arthritis cases, growing awareness about psoriatic arthritis and its medical solutions, broadening spectrum of approved treatments for psoriatic arthritis, government-backed research and development, and increased funding from pharmaceutical enterprises._x000D_
_x000D_
In the upcoming years, the market size for the psoriatic arthritis treatment is expected to steadily rise. By 2029, the growth is set to reach $17.16 billion with a Compound Annual Growth Rate (CAGR) of 9.4%. The key factors contributing to this predicted increase during the forecast period include the advent of individualized medicines, novel biologics and small molecules, broader treatment alternatives, and the rising global aging population. Notable trends within the forecast period encompass advancements in biologics and oral small molecules, focus on specific pathways, the use of telemedicine and remote patient monitoring, an emphasis on patient-centered care, and the utilization of real-world evidence._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp_x000D_
_x000D_
#Which Primay Drivers Are Accelerating Growth in the Psoriatic Arthritis Treatment Market?#_x000D_
The escalation in the incidence of psoriasis and psoriatic arthritis has stimulated the expansion of the psoriatic arthritis treatment market. Both psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory conditions that can drastically impact health and life quality. Psoriasis is linked with inflammatory arthritis, known as psoriatic arthritis (PsA), occurring in 30% of psoriasis patients. For example, in January 2024, the National Library of Medicine, a U.S. government entity, reported that the annual occurrence of psoriatic arthritis among psoriasis patients varies from 1.9% to 2.7% per 100 patients. The probability of PsA development increases over time, with rates of 1.7% at 5 years, 3.1% at 10 years, and up to 20.5% at 30 years post-psoriasis diagnosis. Therefore, the increasing incidence of psoriasis and psoriatic arthritis propels the growth of the market._x000D_
_x000D_
#Which Primary Segments of the Psoriatic Arthritis Treatment Market Are Driving Growth and Industry Transformations?#_x000D_
The psoriatic arthritis treatment market covered in this report is segmented –_x000D_
_x000D_
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes_x000D_
2) By Route Of Administration: Oral, Parenteral, Topical_x000D_
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors_x000D_
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs_x000D_
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics_x000D_
4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=3458&type=smp_x000D_
_x000D_
#Which Regions Are Key Players in the Growth of the Psoriatic Arthritis Treatment Market?#_x000D_
The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
#Which Technological Trends Are Reshaping the Psoriatic Arthritis Treatment Industry Dynamics?#_x000D_
Leading corporations in the psoriatic arthritis treatment market are steadily concentrating on the creation and development of advanced therapeutic solutions like targeted biologic therapy. These novel treatment methods specifically focus on the underlying inflammatory process, ameliorating patient outcomes and boosting the overall quality of life for those suffering from this relentless ailment. Targeted biologic therapy employs specifically engineered medications or substances to interfere with certain molecules that contribute to the proliferation and dissemination of cancerous cells. The goal is to reduce harm to healthy cells while maximizing therapeutic effectiveness. For example, AbbVie, a biopharmaceutical company based in the US, announced in January 2022, that its product, SKYRIZI (risankizumab-rzaa), has received approval from the U.S. Food and Drug Administration (FDA). It’s an IL-23 inhibitor with a designated use for active psoriatic arthritis treatment. It works by inhibiting the p19 subunit of IL-23, targeting inflammation at its origin. There have been significant enhancements in joint symptoms and overall disease activity in the clinical studies, bringing many patients into clinical remission and improving their quality of life. As it is administered via a subcutaneous injection, the treatment offers a convenient patient-friendly option with flexible dosing options that can be adapted to individual needs._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Parameters Are Used to Define the Psoriatic Arthritis Treatment Market?#_x000D_
Psoriatic arthritis treatment refers to a method of treatment or drug used to stop or lessen a chronic inflammatory disease of the joints and the areas where tendons and ligaments attach to the bones (entheses). This treatment focuses on controlling skin involvement and treating joint pain and disability._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3458_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
